Viewing data from:

PALIPERIDONE

ANDA

PALIPERIDONE | A204707 | AMNEAL PHARMACEUTICALS OF NEW YORK LLC

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: INVEGA(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$1.24

per ea

Lowest NADAC/Unit

$0.7658

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
65162028303PALIPERIDONE ER 9 MG TABLET	$1.24	EA	Generic	—	2026-06-17
65162028203PALIPERIDONE ER 6 MG TABLET	$1.09	EA	Generic	—	2026-06-17
65162028103PALIPERIDONE ER 3 MG TABLET	$0.9527	EA	Generic	—	2026-06-17
65162028003PALIPERIDONE ER 1.5 MG TABLET	$0.7658	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 8 NDCs (8 FSS)

Lowest Price

$61.10

Highest Price

$92.61

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
42291-0915-30PALIPERIDONE 1.5MG TAB,SA	$61.10	FSS	AvKare, LLC	06/14/2028
42291-0916-30PALIPERIDONE 3MG TAB,SA	$61.10	FSS	AvKare, LLC	06/14/2028
42291-0917-30PALIPERIDONE 6MG TAB,SA	$61.10	FSS	AvKare, LLC	06/14/2028
42291-0918-30PALIPERIDONE 9MG TAB,SA	$89.30	FSS	AvKare, LLC	06/14/2028
65162-0280-03PALIPERIDONE 1.5MG TAB,SA	$63.37	FSS	AvKare, LLC	06/14/2028
65162-0281-03PALIPERIDONE 3MG TAB,SA	$63.37	FSS	AvKare, LLC	06/14/2028
65162-0282-03PALIPERIDONE 6MG TAB,SA	$63.37	FSS	AvKare, LLC	06/14/2028
65162-0283-03PALIPERIDONE 9MG TAB,SA	$92.61	FSS	AvKare, LLC	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain28 active DMFs5 inactive

26 active API suppliers hold Drug Master Files for this ingredient.

JANSSEN PHARMACEUTICA NVPALIPERIDONE (R076477) DRUG SUBSTANCE

DMF 189152005

JANSSEN PHARMACEUTICA NVPALIPERIDONE PALMITATE (R092670) DRUG SUBSTANCE

DMF 209022007

JUBILANT BIOSYS LTDPALIPERIDONE

DMF 231292009

UNIMARK REMEDIES LTDPALIPERIDONE

DMF 233382010

MATRIX PHARMACORP PRIVATE LTDPALIPERIDONE USP

DMF 233672009

PH HEALTH LTDPALIPERIDONE (NON-STERILE BULK DRUG SUBSTANCE)

DMF 238302010

CADILA PHARMACEUTICALS LTDPALIPERIDONE USP

DMF 238712010

MSN LABORATORIES PRIVATE LTDPALIPERIDONE USP [ROUTE CODE - PA]

DMF 239452010

ALIVUS LIFE SCIENCES LTDPALIPERIDONE

DMF 241632010

AMINO CHEMICALS LTDPALIPERIDONE USP

DMF 242632010

ORCHID PHARMA LTDPALIPERIDONE

DMF 245742011

DR REDDYS LABORATORIES LTDPALIPERIDONE USP

DMF 246002011

APOTEX INCPALIPERIDONE USP

DMF 250732011

MEGAFINE PHARMA P LTDPALIPERIDONE USP (NON- STERILE DRUG SUBSTANCE)

DMF 256422011

SINTENOVO SA DE CVPALIPERIDONE

DMF 262542012

SUN PHARMACEUTICAL INDUSTRIES LTDPALIPERIDONE USP

DMF 268262013

UNICHEM LABORATORIES LTDPALIPERIDONE

DMF 272872013

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDPALIPERIDONE USP

DMF 275032013

TAPI NL BVPALIPERIDONE

DMF 275142013

WOCKHARDT BIO AGPALIPERIDONE USP

DMF 286012014

INTERQUIM SAPALIPERIDONE PALMITATE STERILE

DMF 293282016

EMCURE PHARMACEUTICALS LTDPALIPERIDONE USP

DMF 304152016

PHARMATHEN SAPALIPERIDONE

DMF 310622016

GLAND PHARMA LTDPALIPERIDONE PALMITATE STERILE

DMF 320412017

NEULAND LABORATORIES LTDPALIPERIDONE PALMITATE STERILE

DMF 324352018

APITORIA PHARMA PRIVATE LTDPALIPERIDONE USP

DMF 350002020

MACLEODS PHARMACEUTICALS LTDPALIPERIDONE USP

DMF 352452022

TAPI NL BVPALIPERIDONE PALMITATE STERILE

DMF 419492025

TORRENT PHARMACEUTICALS LTDInactivePALIPERIDONE

DMF 238812010

INTERQUIM SAInactivePALIPERIDONE

DMF 243872010

LUPIN LTDInactivePALIPERIDONE

DMF 243942011

CADILA HEALTHCARE LTDInactivePALIPERIDONE

DMF 249142011

CIPLA LTDInactivePALIPERIDONE USP

DMF 307222016

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (4)

Sort:

#001 — 1.5MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 23, 2019

No patent or exclusivity listings for this strength.

#002 — 3MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 23, 2019

#003 — 6MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 23, 2019

#004 — 9MG

0 patents0 exclusivities▾

TABLET, EXTENDED RELEASE;ORAL | Approved: Sep 23, 2019